levocabastine nasal
Selected indexed studies
- [Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist]. (Nihon Yakurigaku Zasshi, 2002) [PMID:11915520]
- Montelukast sodium combined with levocabastine nasal spray demonstrates high efficacy in treating pediatric allergic rhinitis. (Am J Transl Res, 2025) [PMID:40384999]
- Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis. (Clin Exp Allergy, 1991) [PMID:1680536]
_Worker-drafted node — pending editorial review._
Connections
levocabastine nasal is a side effect of
Sources
- [Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist]. (2002) pubmed
- Montelukast sodium combined with levocabastine nasal spray demonstrates high efficacy in treating pediatric allergic rhinitis. (2025) pubmed
- Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis. (1991) pubmed
- Levocabastine nasal spray significantly improves perennial allergic rhinitis: a single-blind placebo-controlled study. (2010) pubmed
- Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. (1995) pubmed
- The pharmacokinetic properties of topical levocabastine. A review. (1995) pubmed
- Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. (1995) pubmed
- Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis. (1999) pubmed
- Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis. (1991) pubmed
- Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis. (1992) pubmed